?? Podcast Episode: OncoTalks ?? Earlier this week we shared a podcast episode in which VOA's Dr. Paul Conkling and OHC's Dr. David Waterhouse dove into the evolving landscape of second-line treatments for extensive stage small cell lung cancer (SCLC). Today we share their discussion on groundbreaking developments in treating NSCLC patients with METex 14 skipping mutations. In this episode, they delve into the science behind these targeted therapies, their clinical applications, and the impact on patient outcomes. Don’t miss this engaging discussion on a crucial topic in oncology, packed with expert insights! Click here to listen to the OncoTalks episode: "NSCLC METex 14 Skipping." https://lnkd.in/evJwzbmX #OncoTalks #NSCLC #Podcast
Virginia Oncology Associates
医院和医疗保健
Norfolk，Virginia 1,123 位关注者
TOGETHER: A Better Way to Fight Cancer
关于我们
At Virginia Oncology Associates (VOA) we offer comprehensive, community-based multidisciplinary care and research built around our patients. With more than 40 years in practice, and over 450 years of combined experience, we're changing the landscape of patient care. Our dedicated and highly-skilled physicians and staff, who specialize in caring for patients with cancer and blood disorders, provide unparalleled access to the most innovative, advanced therapies and latest technologies throughout Hampton Roads, Northeast North Carolina and the surrounding areas. With 44 board-certified physicians, we offer convenient, compassionate care in 9 locations.
- 网站
-
https://virginiacancer.com/
Virginia Oncology Associates的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 501-1,000 人
- 总部
- Norfolk，Virginia
- 类型
- 私人持股
地点
Virginia Oncology Associates员工
动态
-
???Podcast Episode: OncoTalks??? Join VOA's Dr. Paul Conkling and OHC's Dr. David Waterhouse as they dive into the evolving landscape of second-line treatments for extensive stage small cell lung cancer (SCLC). In this episode, they discuss the latest research, promising therapies, and the profound impact these treatments have on patients' quality of life. This is a must-listen for anyone looking to stay informed about the latest advancements in oncology and to gain expert insights into navigating treatment options. Don't miss out on this engaging and informative conversation! Click here to listen to the OncoTalks episode: "Exploring 2LOT Treatments for Extensive Stage SCLC." https://lnkd.in/em-7Q9HU #OncoTalks #SCLC #Podcast
Exploring Second Line Treatments for Extensive Stage Small Cell Lung Cancer | OncoTalks: Oncology Insights at Your Fingertips
oncotalks.podbean.com
-
We're #hiring a new Telephone Operator in Norfolk, Virginia. Apply today or share this post with your network.
-
We are very proud to have welcomed two amazing gynecologic oncologists (Dr. Danielle Chau and Dr. Devin Miller) to Virginia Oncology Associates who have helped establish a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) program to treat ovarian cancer at Sentara Virginia Beach General Hospital. "In February 2024, Kirby was Dr. Chau’s first patient to undergo HIPEC at Sentara Virginia Beach General Hospital. Dr. Chau removed Kirby’s cancerous organs, then filled Kirby’s abdomen with the heated chemotherapy solution to kill any remaining cancer cells." Click below to read more about HIPEC and Becky Kirby's journey.
We’re honored to share a breakthrough in ovarian cancer care for Hampton Roads! When Becky Kirby was diagnosed with stage 3 ovarian cancer, she became the first patient to receive Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Sentara Virginia Beach General Hospital. Thanks to this innovative treatment, Becky is now in remission and excited about the future. She donated a bell to her surgeon's office for patients to ring when they complete cancer treatment. HIPEC offers a life-extending option for women battling late-stage ovarian cancer for people in the Hampton Roads community. We’re so proud of our dedicated team and the incredible care they provide. ?? Learn more about HIPEC here: https://bit.ly/4fgGeu9. #HIPEC #OvarianCancerAwareness #Breakthrough #Cancer #HealthcareInnovation
-
-
We welcome Taha Sheikh, MD, to Virginia Oncology Associates. Dr. Sheikh joins our team of medical oncologists and hematologists and is taking patients at our Hampton and Newport News locations. Click here to learn more about Dr. Sheikh. https://lnkd.in/envxqJTJ
-
-
November is Lung Cancer Awareness Month. We'd like to share with you our Cancer Care Connections podcast episode where we sat down with Dr. Christopher Paschold, who shared his expertise on the lastest cancer treatments and screening options for Non-Small Cell Lung Cancer. He emphasizes the risk factors involved in developing this cancer, the importance early detection plays in improving outcomes, and the importance of screening for those at high risk. ?? Don't forget to like and share with others! You can find us on Apple Podcast, Spotify, Amazon Music, or anywhere podcasts are available. https://lnkd.in/eNzjFgte #cancercareconnections #voa
-
-
October is Patient-Centered Care Awareness Month—a time to reaffirm our dedication to putting patients first. Mark Fleming, MD reflects on how innovative treatments can truly change lives and the importance of offering more options to all patients. Read more from Dr. Fleming and his colleagues at @Sarah Cannon Research Institute below. #PatientCare #ClinicalTrials
October is Patient-Centered Care Awareness Month. At Sarah Cannon Research Institute, patients are at the heart of everything we do. This month, we’re highlighting a few of the many voices of our dedicated physicians who play a crucial role in ensuring patients not only have access to cutting-edge advancements but also receive the personalized care they need. Swipe through to hear from Dr. Mark Fleming, Cesar Perez M.D., Erika Hamilton, MD, Ishwaria Subbiah, MD, MS, FASCO, and Dr. Charles Anderson, on why clinical trials are essential to delivering patient-centered care. #PatientCare #ClinicalTrials
-
PLEASE JOIN US and Duke Cancer Network for the 25th Annual Educational Conference on November 2, 2024 at Marriott Virginia Beach Oceanfront. The conference will be held from 7:00 AM - 3:30 PM. Learning Objectives: ? Examine emerging research and best evidence-based practice in cancer prevention, management, and survivorship. ? Explore optimization of oncology care utilizing Artificial Intelligence. ? Discuss prostate cancer updates. ? Highlight new concepts and latest developments in the management of breast, head and neck, myeloma, and lung cancer. ? Elevate provider knowledge through discussion of evidence-based guidelines and patient-based case studies. Click here to register https://lnkd.in/ef5tzdhK
-
Back in September, Jared Kobulnicky, MD, was interviewed for a piece about Virginia Oncology Associates in the Oyster Pointer (a Virginia Peninsula publication). Dr. Kobulnicky spoke about the legacy of the practice and how the treatment of cancer has changed over the years. Click here to read more: https://lnkd.in/eDkUvT2h
Virginia Oncology Associates: Compassionate and state-of-the-art care
https://oysterpointer.net
-
?? NEW PODCAST EPISODE ?? Dr. Michael Miller, a radiation oncologist at Virginia Oncology Associates, discusses the incredible advancements in radiation oncology, especially the game-changing TrueBeam Varian linear accelerator, and how these innovations are enhancing treatment precision and patient outcomes. Through Dr. Miller's insights, you'll learn how radiation oncology uses high-precision x-rays to treat tumors with unparalleled accuracy. ?? Don't forget to like and share with others! You can find us on Apple Podcast, Spotify, Amazon Music, or anywhere podcasts are available. https://lnkd.in/eZTtdJqu #cancercareconnections #voa
-